Christine de los Reyes
Corporate Officer/Principal chez ALOPEXX, INC.
Profil
Christine de los Reyes is the founder of Biotechpartnering Solutions LLC, which was founded in 2007.
She currently holds positions as Director at Cognoptix, Inc., Director at Janus Biotherapeutics, Inc., VP-Strategic Planning & Business Development at Alopexx Enterprises LLC, and Chief Business & Commercialization Officer at Alopexx, Inc. She previously held positions as Executive Director-Licensing & Development at Pfizer Inc., Director-Clinical Research at The Mount Sinai Hospital, Head-Business Development at Provenance Biopharmaceuticals Corp., and Associate Professor at Ut College of Pharmacy.
Dr. de los Reyes received an undergraduate degree from Wayne State University (Michigan), a doctorate from The University of Texas at Austin, and an MBA degree from St. Joseph's University.
Postes actifs de Christine de los Reyes
| Sociétés | Poste | Début |
|---|---|---|
| ALOPEXX, INC. | Corporate Officer/Principal | - |
Cognoptix, Inc.
 Cognoptix, Inc. Hospital/Nursing ManagementHealth Services Cognoptix, Inc. develops a non-invasive and predictive eye scanning test for the early detection and diagnosis of alzheimer's disease. It offers technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye. The firm also develops combined optical scanning devices and diagnostic agents for clinical, commercial and academic research use. The company was founded by Lee E. Goldstein and Leo T. Chylack Jr in 2001 and is headquartered in Acton, MA. | Directeur/Membre du Conseil | 08/10/2014 |
Alopexx Enterprises LLC
 Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Corporate Officer/Principal | 01/01/2011 |
Janus Biotherapeutics, Inc.
 Janus Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Janus Biotherapeutics, Inc. is an autoimmunity therapeutics company, which develops orally available compounds for the treatment of autoimmune diseases. The company was founded by Joseph Baron and Grayson Lipford and is headquartered in Wellesley, MA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Christine de los Reyes
| Sociétés | Poste | Fin |
|---|---|---|
| Ut College of Pharmacy | Corporate Officer/Principal | - |
The Mount Sinai Hospital
 The Mount Sinai Hospital Hospital/Nursing ManagementHealth Services The Mount Sinai Hospital provides medical and healthcare services. The company was founded in 1952 and is headquartered in New York, NY. | Directeur Technique/Scientifique/R&D | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
| Biotechpartnering Solutions LLC | Fondateur | - |
Provenance Biopharmaceuticals Corp.
 Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Corporate Officer/Principal | - |
Formation de Christine de los Reyes
| Wayne State University (Michigan) | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
| St. Joseph's University | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PFIZER, INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Cognoptix, Inc.
Cognoptix, Inc. Hospital/Nursing ManagementHealth Services Cognoptix, Inc. develops a non-invasive and predictive eye scanning test for the early detection and diagnosis of alzheimer's disease. It offers technologies to enable non-invasive quantitative measurements of amyloid aggregates in the eye. The firm also develops combined optical scanning devices and diagnostic agents for clinical, commercial and academic research use. The company was founded by Lee E. Goldstein and Leo T. Chylack Jr in 2001 and is headquartered in Acton, MA. | Health Services |
Provenance Biopharmaceuticals Corp.
Provenance Biopharmaceuticals Corp. Medical SpecialtiesHealth Technology Provenance Biopharmaceuticals Corp. engages in the research and development of immune therapeutics for the treatment of cancer. It offers immunocytokine technology, a drug that targets antibodies with immune-stimulating features of cytokines. The company was founded by Stephen D. Gillies and Jason M. Walsh in 2008 and is headquartered in Carlisle, MA. | Health Technology |
Janus Biotherapeutics, Inc.
Janus Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Janus Biotherapeutics, Inc. is an autoimmunity therapeutics company, which develops orally available compounds for the treatment of autoimmune diseases. The company was founded by Joseph Baron and Grayson Lipford and is headquartered in Wellesley, MA. | Health Technology |
The Mount Sinai Hospital
The Mount Sinai Hospital Hospital/Nursing ManagementHealth Services The Mount Sinai Hospital provides medical and healthcare services. The company was founded in 1952 and is headquartered in New York, NY. | Health Services |
Alopexx Enterprises LLC
Alopexx Enterprises LLC BiotechnologyHealth Technology Alopexx Enterprises LLC engages in investing and managing health care companies. It develops medical therapies and devices for infectious diseases, oncology, central nervous system, and orphan diseases. The firm commercializes an alternative for the treatment and prevention of staphylococcal and other bacterial infections and animal vaccines. The company was founded by Daniel R. Vlock, Deborah Ramsdell and Christine de los Reyes in 2011 and is headquartered in Concord, MA. | Health Technology |
| Biotechpartnering Solutions LLC | |
Alopexx, Inc.
 Alopexx, Inc. BiotechnologyHealth Technology Alopexx, Inc. develops novel, broad-spectrum immune medicated therapeutics for the prevention and treatment of bacterial, fungal and parasitic microbial infections. The company was founded by Daniel R. Vlock and Gerald B. Pier and is headquartered in Cambridge, MA. | Health Technology |
